诺和诺德(NVO.N)首席财务官：国际业务上半年增长非常健康，下半年应会继续。

Core Viewpoint - The Chief Financial Officer of Novo Nordisk (NVO.N) stated that the international business experienced very healthy growth in the first half of the year and is expected to continue in the second half [1] Group 1 - The international business of Novo Nordisk showed strong performance in the first half of the year [1] - The company anticipates continued growth in the second half of the year [1]